Question 1

What was the main finding?

Accepted Answer

While all major guidelines agree that assessing cardiovascular risk is crucial for cancer survivors, there is significant disagreement across specialties on how and when to screen, image, and treat these patients.

Question 2

Which guideline offers the most detailed risk assessment?

Accepted Answer

The 2022 European Society of Cardiology (ESC) guideline provides the most comprehensive, five-tiered risk model, whereas oncology guidelines like ASCO and NCCN use simpler models based on age, prior heart disease, or anthracycline dose.

Question 3

What are the major gaps in current guidelines?

Accepted Answer

Current guidelines lack consensus on the use of biomarkers, the exact timing of cardiac imaging, the management of patients on novel cancer therapies, and the implementation of structured cardio-oncology rehabilitation.

How Should We Manage Cardiovascular Risk in Adult Cancer Survivors? A Review of Current Guidelines